Is the FDA doing enough to block entry of illegal drugs?

Jun 11, 2018

Republican and Democratic members on the House Energy and Commerce Committee are questioning the effectiveness of the FDA’s criminal investigators at blocking illegal drugs at U.S. ports of entry.

In a letter to FDA Commissioner Scott Gottlieb, lawmakers expressed concerns over whether or not the agency is appropriately using resources in order to prioritize the seizure of illegal opioids.

During interviews with Reuterssome federal agents complained the FDA was not pursuing cases involving dangerous opioids and drugs such as Kratom, despite the growing public health epidemic.

The committee is asking the FDA to provide statistical data about the cases being generated through the port of entry initiative and its prosecution track record. A spokeswoman for the agency confirmed the FDA had received the letter and plans to respond.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments